Literature DB >> 10872880

Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates.

J E Bailly1, J M McAuliffe, M H Skiadopoulos, P L Collins, B R Murphy.   

Abstract

The Kansas/15626/84 (Ka) and Shipping Fever (SF) strains of bovine parainfluenza virus type 3 (BPIV3) replicate less efficiently than human PIV3 (HPIV3) in the upper and lower respiratory tract of rhesus monkeys, and BPIV3 Ka is also highly attenuated in humans and is in clinical trials as a candidate vaccine against HPIV3. To initiate an investigation of the genetic basis of the observed attenuation phenotype of BPIV3 in primates, the complete genomic sequences of Ka and SF genomes were determined and compared to those of BPIV3 strain 910N and two HPIV3 strains, JS and Wash/47885/57. There is a high degree of identity between the five PIV3 viruses in their 55 nucleotide (nt) leader (83.6%) and 44 nt trailer (93.2%) sequences. The five viruses display amino acid sequence identity ranging from 58.6% for the phosphoprotein to 89.7% for the matrix protein. Interestingly, the majority of amino acid residues found to be variable at a given position in a five-way protein alignment are nonetheless identical within the viruses of either host species (BPIV3 or HPIV3). These host-specific residues might be products of distinct selective pressures on BPIV3 and HPIV3 during evolution in their respective hosts. These host-specific sequences likely include ones which are responsible for the host range differences, such as the efficient growth of BPIV3 in bovines compared to its restricted growth in primates. It should now be possible using the techniques of reverse genetics to import sequences from BPIV3 into HPIV3 and identify those nt or protein sequences which attenuate HPIV3 for primates. This information should be useful in understanding virus-host interactions and in the development of vaccines to protect against HPIV3-induced disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872880     DOI: 10.1023/a:1008130917204

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  52 in total

1.  Molecular cloning and sequence analysis of the human parainfluenza 3 virus RNA encoding the nucleocapsid protein.

Authors:  M S Galinski; M A Mink; D M Lambert; S L Wechsler; M W Pons
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

2.  Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the L protein.

Authors:  M S Galinski; M A Mink; M W Pons
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

3.  Molecular cloning and sequence analysis of the human parainfluenza 3 virus gene encoding the matrix protein.

Authors:  M S Galinski; M A Mink; D M Lambert; S L Wechsler; M W Pons
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

4.  The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles.

Authors:  C J Buchholz; C Retzler; H E Homann; W J Neubert
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

5.  Topography of phosphate residues in Sendai virus proteins.

Authors:  C H Hsu; D W Kingsbury
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

6.  Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins.

Authors:  S Suzu; Y Sakai; T Shioda; H Shibuta
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

7.  An infectious clone of human parainfluenza virus type 3.

Authors:  M A Hoffman; A K Banerjee
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants.

Authors:  R A Karron; M Makhene; K Gay; M H Wilson; M L Clements; B R Murphy
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

9.  Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

Authors:  M H Skiadopoulos; S Surman; J M Tatem; M Paschalis; S L Wu; S A Udem; A P Durbin; P L Collins; B R Murphy
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 10.  Infectious bovine rhinotracheitis, parainfluenza-3, and respiratory coronavirus.

Authors:  S Kapil; R J Basaraba
Journal:  Vet Clin North Am Food Anim Pract       Date:  1997-11       Impact factor: 3.357

View more
  21 in total

1.  Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.

Authors:  A A Haller; T Miller; M Mitiku; K Coelingh
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.

Authors:  J E Bailly; J M McAuliffe; A P Durbin; W R Elkins; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.

Authors:  Matthias Lingemann; Sonja Surman; Emérito Amaro-Carambot; Anne Schaap-Nutt; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

Authors:  A C Schmidt; J M McAuliffe; B R Murphy; P L Collins
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.

Authors:  Linda G Brock; Xiang Liu; Bo Liang; Matthias Lingemann; Xueqiao Liu; Richard Herbert; Ashley D Hackenberg; Ursula J Buchholz; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

6.  Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.

Authors:  A C Schmidt; J M McAuliffe; A Huang; S R Surman; J E Bailly; W R Elkins; P L Collins; B R Murphy; M H Skiadopoulos
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics.

Authors:  Jason T Newman; Sonja R Surman; Jeffrey M Riggs; Chris T Hansen; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

8.  Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States.

Authors:  Dan Qiao; Bruce H Janke; Subbiah Elankumaran
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Phylogenetic analysis of the bovine parainfluenza virus type 3 from cattle herds revealing the existence of a genotype A strain in China.

Authors:  Yong-Jun Wen; Xin-Chuan Shi; Feng-Xue Wang; Wei Wang; Shu-Qin Zhang; Guo Li; Ni Song; Li-Zhi Chen; Shi-Peng Cheng; Hua Wu
Journal:  Virus Genes       Date:  2012-08-26       Impact factor: 2.332

10.  Molecular characterization of glycoprotein genes and phylogenetic analysis of two swine paramyxoviruses isolated from United States.

Authors:  Dan Qiao; Bruce H Janke; Subbiah Elankumaran
Journal:  Virus Genes       Date:  2009-04-01       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.